Question
Is eye health impacted by MGUS, Smoldering Myeloma or Multiple Myeloma or its treatments?
Description
Myeloma experts Rahul Banerjee, MD and Andrew Cowan, MD of the Fred Hutchinton are interested in knowing if your eye health has been impacted by precursor conditions or multiple myeloma, or drugs used to treat these conditions. The researchers are interested in gathering information about eye health, medications that might affect eye health and quality of life among patients with these conditions.
Impact
Myeloma specialists could change clinical practice recommendations based on these findings to preserve eye health or limit eye-related conditions.
Research Partners
Rahul Banerjee, MD, Fred Hutchinson Cancer Center and Andrew Cowan, MD, Fred Hutchinson Cancer Center
Type
Survey
Time
3-5 minutes
Who Can Join
Patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma (SMM) or multiple myeloma who have or have not received treatment.
Question
Is eye health impacted by MGUS, Smoldering Myeloma or Multiple Myeloma or its treatments?
Description
Myeloma experts Rahul Banerjee, MD and Andrew Cowan, MD of the Fred Hutchinton are interested in knowing if your eye health has been impacted by precursor conditions or multiple myeloma, or drugs used to treat these conditions. The researchers are interested in gathering information about eye health, medications that might affect eye health and quality of life among patients with these conditions.
Impact
Myeloma specialists could change clinical practice recommendations based on these findings to preserve eye health or limit eye-related conditions.
Research Partners
Rahul Banerjee, MD, Fred Hutchinson Cancer Center and Andrew Cowan, MD, Fred Hutchinson Cancer Center
Type
Survey
Time
3-5 minutes
Who Can Join
Patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering myeloma (SMM) or multiple myeloma who have or have not received treatment.
Trending Articles
Upcoming Events
Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.